COMPARATIVE INVITRO ACTIVITY OF 5 QUINOLINE DERIVATIVES AND 5 OTHER ANTIMICROBIAL AGENTS USED IN ORAL-THERAPY

被引：70

作者：

HOOGKAMPKORSTANJE, JAA

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1984年 / 3卷 / 04期

关键词：

D O I：

10.1007/BF01977489

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：333 / 338

页数：6

共 10 条

[1] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].

BAUERNFEIND, A ;

PETERMULLER, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115

[2] INVITRO ANTI-BACTERIAL ACTIVITY OF NORFLOXACIN COMPARED WITH 8 OTHER ANTI-MICROBIAL AGENTS [J].

BODY, BA ;

FROMTLING, RA ;

SHADOMY, S ;

SHADOMY, HJ .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) :230-234

[3] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].

CRUMP, B ;

WISE, R ;

DENT, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786

[4] PHARMACOKINETICS OF NORFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS WITH RENAL AND HEPATIC DAMAGE [J].

EANDI, M ;

VIANO, I ;

DINOLA, F ;

LEONE, L ;

GENAZZANI, E .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) :253-259

[5] THE INHIBITORY QUOTIENT - A METHOD FOR INTERPRETING MINIMUM INHIBITORY CONCENTRATION DATA [J].

ELLNER, PD ;

NEU, HC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (14) :1575-1578

[6]

Hoogkamp-Korstanje J A, 1982, Eur J Clin Microbiol, V1, P166, DOI 10.1007/BF02019618

[7]

SCHWARTZ DE, 1970, CHEMOTHERAPY, V15, P1575

[8]

THABAUT A, 1982, PATHOLOGIE BIOL, V6, P394

[9]

VONBRUHL P, 1981, ARZNEIMITTELFORSCHUN, V31, P2

[10] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].

WISE, R ;

ANDREWS, JM ;

EDWARDS, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564

← 1 →